Reaction Biology
  • English
  • 中文
  • Overview
  • Services
    • Box 1
      • Target-specific Assays
      • Integrated Kinase Discovery Services
        • Kinase Assays Services
        • Kinase Panel Screening
        • Cellular Kinase Assays
          • BaF3 Cell Proliferation Assay
          • Cellular Phosphorylation Assay
          • NanoBRET TE Intracellular Kinase Assay
        • EGFR Drug Discovery
        • Kinase SubstrateFinder
        • KinaseFinder
        • Customized Kinase Drug Discovery
        • In Vivo Kinase Activity Models
        • Recombinant Kinase-related Products
      • Epigenetic Assays
        • Cell-based Epigenetic Assays
        • Reader Domain Assays
        • Methyltransferase Assays
        • Demethylase Assays
        • Histone Acetyltransferase Assays (HAT)
        • Histone Deacetylase (HDAC) & Sirtuin Assays
        • Isocitrate Dehydrogenase Assays (IDH)
        • Customized Epigenetic Drug Discovery
      • RAS-related Assays
      • Immune Checkpoint Assays
      • Targeted Protein Degradation Assays
      • PARP Assays
      • Phosphatase Assays
      • Protease Assays
      • Kinesin ATPase Assays
      • Apoptosis Pathway Assays
      • Metabolic Pathway Assays
        • Isocitrate Dehydrogenase Assays (IDH)
        • Carboxylase Assays
        • NAD(P)H Dehydrogenase (NQO)
        • Nucleotide Metabolism Pathway Assays
      • Phosphodiesterase Assays (PDE)
      • Ubiquitin-Proteasome Pathway Assays
      • Ion Channel Assays
      • GPCR Assays
      • Nuclear Receptor Assays
      • COVID-19-related Assays
        • SARS-CoV-2 S Protein and ACE2 Binding Assay
        • SARS-CoV-2-related Protease Assays
      • Additional Targets
        • Heat Shock Protein Assays
        • Replication-related Assays
      • Protein Production and Assay Development
      • Custom Antibody Services
      • Custom Peptide Services
    • box 2
      • Cell-based Assays
      • Target-specific Cell-based Assays
        • Kinase Assays
        • Intracellular PARP Assays
        • Epigenetic Assays
        • GPCR Assays
        • Ion Channel Assays
      • 2D Cell-based Assays
        • ProLiFiler™ Cancer Cell Panel Screening
        • Cell Proliferation and Viability Assays
        • Cell Death Assays
        • Migration Assay
      • 3D Cell-based Assays
        • 3D ProLiFiler™ Spheroid Cancer Cell Panel Screening
        • 3D Tumor Spheroid Assay
        • Soft Agar Assay
        • Angiogenesis Assay
      • Cell Line Generation
      • Assay Platforms
      • Biophysical Assays
      • Surface Plasmon Resonance (SPR)
      • Isothermal Titration Calorimetry (ITC)
      • Microscale Thermophoresis (MST)
      • Thermal Shift Assay (TSA)
      • ADME & Safety
      • In Vitro Safety Screening
      • Cardiac Safety Assessment
      • Cytochrome P450 Assays
      • In Vivo PK/PD
      • Maximum-Tolerated Dose
    • Box 3
      • In Vivo Pharmacology
      • Xenograft Models
        • Subcutaneous Tumor Models
        • SubQperior Tumor Models
        • Orthotopic Tumor Models
        • Metastasis Models
      • In Vivo Hollow Fiber Model
      • In Vivo Kinase Activity Models
      • Immuno-Oncology Tumor Models
        • CAR-T Cell Therapy Platform
        • Humanized Xenograft Models
        • Humanized Syngeneic Models
        • Syngeneic Mouse Models
        • SubQperior Panel Screen
        • Mouse-derived Isograft Models (MDI)
        • Immunophenotyping
      • Immuno-Oncology Platform
      • Immuno-Oncology Tumor Models
        • CAR-T Cell Therapy Platform
        • Humanized Xenograft Models
        • Humanized Syngeneic Models
        • Syngeneic Mouse Models
        • SubQperior™ Panel Screen
        • Mouse-derived Isograft Tumor Models (MDI)
        • Immunophenotyping
      • Immuno-Oncology Assays
        • T Cell Killing Assays
        • T Cell Assays
        • NK Cell Killing Assays
        • Immune Checkpoint Assays
        • Macrophage Cell-based Assays
      • Biomarker Discovery
      • Genetic Biomarkers
        • qPCR
        • Biomarker Analysis Tool
      • Protein Biomarkers
        • Flow Cytometry Applications
        • Multiplex Assays
        • ELISA / Western Blot / Alpha Technology
      • Phenotypic Biomarkers
        • Cell Death Mechanism
        • MOA Finder
      • Immunophenotyping
        • Immunohistochemistry and TMA
        • Immunophenotyping by Flow Cytometry
        • Multiplex Immune Assays
      • Bioprocessing
      • Bioassay and Potency Testing
  • Products
    • Box 1
      • Kinase-related Products
      • Active Protein Kinases
      • Active Lipid Kinases
      • Additional Kinase Variants
      • Recombinant Kinase Substrates
      • Custom Protein Production
      • Protein Production and Assay Development
      • Assay Kits
      • BromoMELT Assay Kit
    • Box 2
      • Epigenetic-related Products
      • All Epigenetic-related Products
      • Methyltransferase Proteins
      • Methyltransferase Substrates
      • Reader Domain Proteins
      • Deacetylase Proteins
      • Demethylase Proteins
      • DNA Repair Proteins
      • IDH Proteins
      • PARP Proteins
      • Assay Kits
      • Epigenetic Inhibitors
    • Box 3
      • Other Products
      • Ras-Related Proteins
      • NQO Proteins
      • Apoptosis Proteins
      • NUDIX & Nucleotide Pool Sanitation Proteins
      • Miscellaneous Proteins
      • Deiminase Proteins
      • SARS-CoV-2-related Proteins
  • Resources
    • box 1
      • Tools
      • Biomarker Analysis Tool
      • Kinase Mapper
      • MoA Finder
      • Tumor Microarray Gallery
    • box 2
      • Reading room
      • Resource Library
      • Blog
      • FAQ
  • Company
    • About us
    • Meet the Team
    • What people are saying
    • News and Press Releases
    • Events
    • Careers
  • Contact
  • English
  • 中文
  • Overview
  • Services
    • Target-specific Assays
      • Kinase Assays
        • Kinase Assay Services
        • Kinase Panel Screening
        • Cellular Kinase Assays
          • BaF3 Cell Proliferation Assay
          • Cellular Phosphorylation Assay
          • NanoBRET Intracellular Kinase Assay
        • EGFR Drug Discovery
        • Kinase SubstrateFinder
        • Kinase Finder
        • Customized Kinase Drug Discovery
        • In Vivo Kinase Activity Models
        • Recombinant Kinase-related Products
      • Epigenetic Assays
        • Cell-based Epigenetic Assays
        • Reader Domain Assays
        • Methyltransferase Assays
        • Demethylase Assays
        • Histone Acetyltransferase Assays (HAT)
        • Histone Deacetylase (HDAC) & Sirtuin Assays
        • Isocitrate Dehydrogenase Assays (IDH)
        • Customized Epigenetic Drug Discovery
      • RAS-related Assays
      • Immune Checkpoint Assays
      • Targeted Protein Degradation Assays
      • PARP Assays
      • Phosphatase Assays
      • Protease Assays
      • Kinesin ATPase Assays
      • Apoptosis Pathway Assays
      • Metabolic Pathway Assays
        • Isocitrate Dehydrogenase Assays (IDH)
        • Carboxylase Assays
        • NAD(P)H Dehydrogenase (NQO)
        • Nucleotide Metabolism Pathway Assays
      • Phosphodiesterase Assays (PDE)
      • Ubiquitin-Proteasome Pathway Assays
      • Ion Channel Assays
      • GPCR Assays
      • Nuclear Receptor Assays
      • COVID-19-related Assays
        • SARS-CoV-2 S Protein and ACE2 Binding Assay
        • SARS-CoV-2-related Protease Assays
      • Additional Targets
        • Heat Shock Protein Assays
        • Replication-related Assays
      • Protein Production and Assay Development
      • Custom Antibody Services
      • Custom Peptide Services
    • Cell-based Assays
      • Target-specific Cell-based Assays
        • Kinase Assays
        • Intracellular PARP Assays
        • Epigenetic Assays
        • GPCR Assays
        • Ion Channel Assays
      • 2D Cell-based Assays
        • ProLiFiler™ Cancer Cell Panel Screening
        • Cell Proliferation and Viability Assays
        • Cell Death Assays
        • Migration Assay
      • 3D Cell-based Assays
        • 3D Tumor Spheroid Assay
        • Soft Agar Assay
        • Angiogenesis Assay
      • Cell Line Generation
      • Assay Platforms
    • Biophysical Assays
      • Surface Plasmon Resonance (SPR)
      • Isothermal Titration Calorimetry (ITC)
      • Microscale Thermophoresis (MST)
      • Thermal Shift Assay (TSA)
    • ADME & Safety
      • In Vitro Safety Screening
      • Cardiac Safety Assessment
      • Cytochrome P450 Assays
      • In Vivo PK/PD
      • Maximum-Tolerated Dose
    • In Vivo Pharmacology
      • Xenograft Models
      • In Vivo Hollow Fiber Model
      • In Vivo Kinase Activity Models
      • Immuno-Oncology Tumor Models
        • Humanized Xenograft Models
        • Humanized Syngeneic Models
        • Syngeneic Mouse Models
        • SubQperior™ Panel Screen
        • Mouse-derived Isograft Tumor Models (MDI)
        • Immunophenotyping
    • Immuno-Oncology Platform
      • Immuno-Oncology Tumor Models
        • Humanized Xenograft Models
        • Humanized Syngeneic Models
        • Syngeneic Mouse Models
        • SubQperior™ Panel Screen
        • Mouse-derived Isograft Models (MDI)
        • Immunophenotyping
      • Immuno-Oncology Assays
        • T Cell Killing Assays
        • T Cell Assays
        • NK Cell Killing Assays
        • Immune Checkpoint Assays
        • Macrophage Cell-based Assays
    • Biomarker Discovery
      • Genetic Biomarkers
        • qPCR
        • Biomarker Analysis Tool
      • Protein Biomarkers
        • Flow Cytometry Applications
        • Multiplex Assays
        • ELISA / Western Blot / Alpha Technology
      • Phenotypic Biomarkers
        • Cell Death Mechanism
        • MOA Finder
      • Immunophenotyping
        • Immunohistochemistry and TMA
        • Immunophenotyping by Flow Cytometry
        • Multiplex Immune Assays
    • Bioprocessing
      • Bioassay and Potency Testing
  • Products
    • Kinase-related Products
      • Active Protein Kinases
      • Active Lipid Kinases
      • Additional Kinase Variants
      • Recombinant Kinase Substrates
    • Custom Protein Production
      • Protein Production and Assay Development
    • Assay Kits
      • BromoMELT Assay Kit
    • Epigenetic-related Products
      • All Epigenetic-related Products
      • Methyltransferase Proteins
      • Methyltransferase Substrates
      • Reader Domain Proteins
      • Deacetylase Proteins
      • Demethylase Proteins
      • DNA Repair Proteins
      • IDH Proteins
      • PARP Proteins
      • Assay Kits
      • Epigenetic Inhibitors
    • Other Products
      • Ras-Related Proteins
      • NQO Proteins
      • Apoptosis Proteins
      • NUDIX & Nucleotide Pool Sanitation Proteins
      • Miscellaneous Proteins
      • Deiminase Proteins
      • SARS-CoV-2-related Proteins
  • Resources
    • Tools
      • Biomarker Analysis Tool
      • Kinase Mapper
      • MoA Finder
    • Reading room
      • Resource Library
      • Blog
      • FAQ
  • Company
    • About us
    • Meet the Team
    • What people are saying
    • News and Press Releases
    • Events
    • Careers
  • Contact
Comprehensive characterization of CDK inhibitors using a complete panel of all 20 human cyclin-dependent kinases

Comprehensive characterization of CDK inhibitors using a complete panel of all 20 human cyclin-dependent kinases

by Reaction Biology | Nov 20, 2023

Novel inhibitors of breast cancer relevant kinases Brk and HER2. Medicinal Chemistry Communications, 2014

by Reaction Biology | Nov 20, 2023

Spheroid-based human endothelial cell microvessel formation in vivo. Nature Protocols, 2009

Spheroid-based human endothelial cell microvessel formation in vivo. Nature Protocols, 2009

by Reaction Biology | Nov 20, 2023

IC50 profiling against 320 protein kinases: Improving the accuracy of kinase inhibitor selectivity testing.

IC50 profiling against 320 protein kinases: Improving the accuracy of kinase inhibitor selectivity testing.

by Reaction Biology | Nov 20, 2023

Application of biochemical and cellular activity assays for the characterization of inhibitors targeting disease-relevant mutants of the EGF receptor

Application of biochemical and cellular activity assays for the characterization of inhibitors targeting disease-relevant mutants of the EGF receptor

by Reaction Biology | Nov 20, 2023

« Older Entries
Next Entries »
  • Terms and Conditions
  • Privacy Policy
  • Site Map
  • Contact Us
  • Company
  • FAQ
  • Facebook
  • Google
  • Twitter
© 2024 Reaction Biology. All Rights Reserved